These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 38783892)

  • 1. CD44 and its implication in neoplastic diseases.
    Xu Y; Bai Z; Lan T; Fu C; Cheng P
    MedComm (2020); 2024 Jun; 5(6):e554. PubMed ID: 38783892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44 as a tumor biomarker and therapeutic target.
    Xu H; Niu M; Yuan X; Wu K; Liu A
    Exp Hematol Oncol; 2020 Dec; 9(1):36. PubMed ID: 33303029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β1 promotes epithelial-to-mesenchymal transition and stemness of prostate cancer cells by inducing PCBP1 degradation and alternative splicing of CD44.
    Chen Q; Gu M; Cai ZK; Zhao H; Sun SC; Liu C; Zhan M; Chen YB; Wang Z
    Cell Mol Life Sci; 2021 Feb; 78(3):949-962. PubMed ID: 32440711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44: A New Prognostic Marker in Colorectal Cancer?
    Ziranu P; Pretta A; Aimola V; Cau F; Mariani S; D'Agata AP; Codipietro C; Rizzo D; Dell'Utri V; Sanna G; Moledda G; Cadoni A; Lai E; Puzzoni M; Pusceddu V; Castagnola M; Scartozzi M; Faa G
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biology and role of CD44 in cancer progression: therapeutic implications.
    Chen C; Zhao S; Karnad A; Freeman JW
    J Hematol Oncol; 2018 May; 11(1):64. PubMed ID: 29747682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoform switch of CD44 induces different chemotactic and tumorigenic ability in gallbladder cancer.
    Miwa T; Nagata T; Kojima H; Sekine S; Okumura T
    Int J Oncol; 2017 Sep; 51(3):771-780. PubMed ID: 28677740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44: A Multifunctional Mediator of Cancer Progression.
    Hassn Mesrati M; Syafruddin SE; Mohtar MA; Syahir A
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CD44 standard isoform contributes to radioresistance of pancreatic cancer cells.
    Tsubouchi K; Minami K; Hayashi N; Yokoyama Y; Mori S; Yamamoto H; Koizumi M
    J Radiat Res; 2017 Nov; 58(6):816-826. PubMed ID: 29106581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches.
    Williams K; Motiani K; Giridhar PV; Kasper S
    Exp Biol Med (Maywood); 2013 Mar; 238(3):324-38. PubMed ID: 23598979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding Hyaluronan Receptor (CD44) Interaction, HA-CD44 Activated Potential Targets in Cancer Therapeutics.
    Chaudhry GE; Akim A; Naveed Zafar M; Safdar N; Sung YY; Muhammad TST
    Adv Pharm Bull; 2021 May; 11(3):426-438. PubMed ID: 34513617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44: structure, function, and association with the malignant process.
    Naor D; Sionov RV; Ish-Shalom D
    Adv Cancer Res; 1997; 71():241-319. PubMed ID: 9111868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer.
    Inoue K; Fry EA
    Genet Epigenet; 2015; 7():19-32. PubMed ID: 26692764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion.
    Gaiteiro C; Soares J; Relvas-Santos M; Peixoto A; Ferreira D; Paulo P; Brandão A; Fernandes E; Azevedo R; Palmeira C; Freitas R; Miranda A; Osório H; Prieto J; Lima L; Silva AMN; Santos LL; Ferreira JA
    Theranostics; 2022; 12(7):3150-3177. PubMed ID: 35547758
    [No Abstract]   [Full Text] [Related]  

  • 15. Rheostatic CD44 isoform expression and its association with oxidative stress in human malignant mesothelioma.
    Chew SH; Okazaki Y; Akatsuka S; Wang S; Jiang L; Ohara Y; Ito F; Saya H; Sekido Y; Toyokuni S
    Free Radic Biol Med; 2017 May; 106():91-99. PubMed ID: 28185919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44 splice isoform switching determines breast cancer stem cell state.
    Zhang H; Brown RL; Wei Y; Zhao P; Liu S; Liu X; Deng Y; Hu X; Zhang J; Gao XD; Kang Y; Mercurio AM; Goel HL; Cheng C
    Genes Dev; 2019 Feb; 33(3-4):166-179. PubMed ID: 30692202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion.
    Afify A; Purnell P; Nguyen L
    Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers.
    Olsson E; Honeth G; Bendahl PO; Saal LH; Gruvberger-Saal S; Ringnér M; Vallon-Christersson J; Jönsson G; Holm K; Lövgren K; Fernö M; Grabau D; Borg A; Hegardt C
    BMC Cancer; 2011 Sep; 11():418. PubMed ID: 21957977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal splice isoform of CD44 (CD44s) promotes EMT/invasion and imparts stem-like properties to ovarian cancer cells.
    Bhattacharya R; Mitra T; Ray Chaudhuri S; Roy SS
    J Cell Biochem; 2018 Apr; 119(4):3373-3383. PubMed ID: 29130517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD44s and CD44v8-10 isoforms confer acquired resistance to osimertinib by activating the ErbB3/STAT3 signaling pathway.
    Liu YN; Tsai MF; Wu SG; Chang TH; Shih JY
    Life Sci; 2024 Jan; 336():122345. PubMed ID: 38092140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.